key: cord-0722927-0gylonyz authors: Vahedi, Arshia; Tabasi, Farhad; Monjazebi, Fateme; Hashemian, Seyed Mohammad Reza; Tabarsi, Payam; Farzanegan, Behrooz; Malekmohammad, Majid; Salimi, Alireza; Salimi, Morteza; Raoufy, Mohammad Reza; Jamaati, Hamidreza; Velayati, Ali Akbar title: Clinical Features and Outcomes of ICU Patients with COVID-19 Infection in Tehran, Iran: a Single-Centered Retrospective Cohort Study date: 2020-12-03 journal: Tanaffos DOI: nan sha: 918a0a724d4bcc68f5ae6005109bdbb0b0c330fd doc_id: 722927 cord_uid: 0gylonyz BACKGROUND: The clinical characteristics of the novel coronavirus disease (COVID-19) were diverse and unspecific. Here, we identified the associated factors with surviving of COVID-19 ICU patients based on the clinical characteristics of patients admitted to one of the Corona Centre Hospitals of Iran. MATERIALS AND METHODS: This cohort study was performed retrospectively from February to June 2020 on 133 COVID-19 patients admitted to 4 intensive care units of Masih Daneshvari Hospital in Tehran, Iran. Demographic, medical, clinical manifestation at admission, laboratory parameters and outcome data were obtained from medical records. Also the SOFA and APACHE II scores were calculated. All data were analyzed using SPSS (version 23, IBM Corp.) software. RESULTS: The median (IQR) age of the patients was 62.0 (54.0–72.0) years in total. RT-PCR of throat swab SARS-CoV-2 in 80 patients (60.2%) was positive. Total mortality rate was 57.9 percent (77 patients). Dyspnea, hypertension and chronic pulmonary diseases were significantly common in non-survivors than survivors (p<0.05). Both SOFA and APACHE II scores were significantly higher in the non-survivors (p<0.05). Also other significant differences were observed in other parameters of the study. CONCLUSION: The mortality rate of COVID-19 patients admitted to ICU is generally high. Dyspnea as initial presentation and comorbidity, especially hypertension and pulmonary diseases, may be associated with higher risk of severe disease and consequent mortality rate. Also, higher SOFA and APACHE II scores could indicate higher mortality in patients admitted to ICU. Novel coronavirus pneumonia was first reported in late December 2019 in Wuhan, Hubei, China (1) . Since then, the coronavirus disease 2019 (COVID-19) has spread rapidly across China and other countries, and the outbreak has become a worldwide concern and public health emergency (2) . Until October 11 2020, more than 37 million confirmed cases and one million deaths from COVID-19 were TANAFFOS reported globally (3) . In Iran, according to the latest epidemiologic data, at least 500,000 laboratory confirmed cases and 29,000 deaths of COVID-19 was reported until October 14, 2020 (3, 4) ; although the incidence of COVID-19 deaths tends to be higher in forthcoming future. The pathogen is a novel betacoronavirus responsible for severe acute respiratory syndrome (SARS), named SARS-coronavirus 2 (SARS-CoV-2) (5) . Coronaviruses are enveloped, single stranded RNA viruses with rapid mutation and recombination (6) . This cohort study was performed retrospectively from February to June 2020 on patients admitted to 4 intensive care units of Masih Daneshvari Hospital in Tehran, Iran. This hospital was the designated as the Corona Center Hospital to treat SARS-CoV-2 pneumonia from the initial days of corona epidemics. All patients admitted to ICUs with diagnosis of SARS-CoV-2 pneumonia according to WHO interim guidance were enrolled in this study (11) . We also calculated sepsis-related organ failure assessment (SOFA) and APACHE II score to predict and estimate mortality in patients admitted to the ICU, based on clinical data and laboratory values (12, 13) . All continuous variables were presented as the median (IQR), and categorical variables were presented as N (%), Table 3 . The median of RR and O2 saturation was significantly higher and lower in non-survivors compared to survivors, respectively (p<0.05, Table 3 ). Table 4 . Also non-critical patients could be treated with close follow-up, until the symptoms resolved or further management was needed (14, 15) . human-to-human contact, and the mortality rate is generally considered lower than other related infections such as SARS and MERS. Though, in our study, the mortality rate of critically ill patients was higher than SARS infection (16) (17) (18) . This was in line with most critical care-based studies (19, 20) . The number of men who died from the disease is two times higher than women in our study. However, in this study the infected males were approximately two times higher than females. Primary studies indicated that nearly 70% of patients infected with SARS-CoV-2 were male (1, 15 The mortality rate of patients admitted to ICU is generally high. The comorbidity, especially hypertension and pulmonary diseases may be associated with higher risk of severe disease and consequent mortality rate. Also, dyspnea as initial presentation may indicate more diffuse and severe SARS-CoV-2 infections . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China World Health Organization. Statement on the second meeting of the International Health Regulations Emergency Committee regarding the outbreak of novel coronavirus World Health Organization World Health Organization (WHO) Islamic Republic of); The current COVID-19 situation Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Clinical Characteristics of Coronavirus Disease 2019 in China COVID-19): A Perspective from China Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases Clinical management of severe acute respiratory infection when novel coronavirus ( nCoV) infection is suspected: interim guidance The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine APACHE II: a severity of disease classification system A Novel Coronavirus from Patients with Pneumonia in China Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Critically ill patients with severe acute respiratory syndrome Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome Short-term outcome of critically ill patients with severe acute respiratory syndrome Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies Coronavirus as a possible cause of severe acute respiratory syndrome Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome Inflammation During Virus Infection: Swings and Roundabouts. InDynamics of Immune Activation in Viral Diseases Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome SARS: systematic review of treatment effects Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19) Dexamethasone in hospitalized patients with Covid-19-preliminary report SARS and MERS: recent insights into emerging coronaviruses Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19 Presymptomatic Transmission of SARS-CoV-2 -Singapore COVID-19 Transmission Within a Family Cluster by Presymptomatic Carriers in China Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study A major outbreak of severe acute respiratory syndrome in Hong Kong Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany Enteric involvement of severe acute respiratory syndromeassociated coronavirus infection Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV Hypermagnesemia is a strong independent risk factor for mortality in critically ill patients: results from a cross-sectional study Association of Serum Magnesium on Mortality in Patients Admitted to the Intensive Cardiac Care Unit Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study Hypermagnesemia and hypocalcemia as predictors of high mortality in critically ill pediatric patients Severe acute respiratory syndrome: radiographic and CT findings Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease Imaging profile of the COVID-19 infection: radiologic findings and literature review Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China Emerging 2019 novel coronavirus (2019-nCoV) pneumonia Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China We would like to express our special thanks to all staff of Archives and Documents Unit of the Masih Daneshvari Hospital and also Deputy of Research of the Hospital and Shahid Beheshti University of Medical Sciences .